Your browser doesn't support javascript.
loading
TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes.
Gurnari, Carmelo; Pagliuca, Simona; Guan, Yihong; Adema, Vera; Hershberger, Courtney E; Ni, Ying; Awada, Hassan; Kongkiatkamon, Sunisa; Zawit, Misam; Coutinho, Diego F; Zalcberg, Ilana R; Ahn, Jae-Sook; Kim, Hyeoung-Joon; Kim, Dennis Dong Hwan; Minden, Mark D; Jansen, Joop H; Meggendorfer, Manja; Haferlach, Claudia; Jha, Babal K; Haferlach, Torsten; Maciejewski, Jaroslaw P; Visconte, Valeria.
Afiliação
  • Gurnari C; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
  • Pagliuca S; Department of Biomedicine and Prevention, PhD in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Rome, Italy.
  • Guan Y; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
  • Adema V; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
  • Hershberger CE; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Ni Y; Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
  • Awada H; Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
  • Kongkiatkamon S; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
  • Zawit M; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
  • Coutinho DF; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
  • Zalcberg IR; Divisão de Laboratórios do Centro de Transplantes de Medula Óssea (CEMO), Instituto Nacional do Câncer (INCA), Rio de Janeiro, RJ, Brazil.
  • Ahn JS; Divisão de Laboratórios do Centro de Transplantes de Medula Óssea (CEMO), Instituto Nacional do Câncer (INCA), Rio de Janeiro, RJ, Brazil.
  • Kim HJ; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju, Republic of Korea.
  • Kim DDH; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju, Republic of Korea.
  • Minden MD; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada.
  • Jansen JH; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada.
  • Meggendorfer M; Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands; and.
  • Haferlach C; Munich Leukemia Laboratory (MLL), Munich, Germany.
  • Jha BK; Munich Leukemia Laboratory (MLL), Munich, Germany.
  • Haferlach T; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
  • Maciejewski JP; Munich Leukemia Laboratory (MLL), Munich, Germany.
  • Visconte V; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
Blood Adv ; 6(1): 100-107, 2022 01 11.
Article em En | MEDLINE | ID: mdl-34768283
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Dioxigenases Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2022 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Dioxigenases Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2022 Tipo de documento: Article País de publicação: Estados Unidos